Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Swedish Medical Products Agency and Ethics Committee have announced that they approve Gedea’s first clinical study. The study is an important step prior to CE marking ofpHyph, which is a completely new type of treatment for vaginal infection. pHyph is expected to be able to treat both vaginal fungal infections and bacterial vaginosis and may become the first product on the market for treatment of both types of infection.
Meet Thomas Andersson, our new Senior Advisor Business Development. How could he be of help to your startup company?
Sinntaxis announces today that it has entered into an option agreement with Acturum for an exclusive license to drug candidate AZD2066 for the development of a potentially pioneering treatment helping stroke survivors recover brain function.
Eleven presentations of HUMIRA® (adalimumab) and pipeline data showcase breadth and depth of robust gastroenterology portfolio
A Comparison of Scientific Publications in 10 European Life Science Clusters
“We need to improve framework conditions for SME´s and make sure that Danish and Swedish national life science strategies are aligned around Medicon Valley” were two of the key message from Danish Minister for Industry, Business and Financial Affairs, Rasmus Jarlov, that went down particularly well with the +200 participants at the Medicon Valley Alliance Annual Meeting 2018